Scientists have visualised and investigated a key molecular pathway that could one day help treat inflammation, diabetes, cancer, infectious diseases and potentially even COVID-19.
A Griffith University-led research team has discovered how a therapeutic target common among debilitating neurodegenerative disorders is activated, which could help accelerate drug development.